InvestorsHub Logo
icon url

Poor Man -

03/18/22 9:00 AM

#452375 RE: dennisdave #452369

I guess that’s good news?

That would be consistent with Mav’s take on where things stand.
icon url

trocprofit

03/18/22 10:37 AM

#452399 RE: dennisdave #452369

There is no indication that they have applied for MHRA approval, or do you have some information that they did?. And, I, like many, believe it would not be possible to apply and submit unblinded TLD data without PR'ing it.
icon url

X Master

03/18/22 11:28 AM

#452406 RE: dennisdave #452369

I would not doubt it that we see both at the same time. That would be a good day!
icon url

meirluc

03/18/22 12:21 PM

#452436 RE: dennisdave #452369

dennisdave, please share with us what are the solid indications that lead you to believe that the journal publication has encountered some tough and difficult obstacles and that NWBO had therefore decided to postpone the publication and still go for RA approval.

Also what information do you have that NWBO had requested an MHRA approval and if the MHRA had dismissed the request, production of DCVax-L in the UK would have already been terminated?
icon url

flipper44

03/18/22 1:55 PM

#452491 RE: dennisdave #452369

Ignoring most of this post as well as it is full of useless rumors, you don’t seem to understand the MHRA process. First there is a GMP commercial application. It is 99.9999% certain that the public will find out about such application long before they find out about an MHRA GMP commercial approval.
icon url

biosectinvestor

06/07/22 11:14 AM

#484040 RE: dennisdave #452369

Interesting.